How many drugs treat Angina Pectoris Prevention?

Drug Landscape tracks 2 marketed treatments for Angina Pectoris Prevention (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/angina-pectoris-prevention.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Angina Pectoris Prevention — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Angina Pectoris Prevention (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Angina Pectoris Prevention, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Nitroglycerin	glyceryl trinitrate	Fougera	Nitrate Vasodilator [EPC]	guanylate cyclase		1981-01-01
nitroglycerine	nitroglycerine	University Hospital, Ghent		Atrial natriuretic peptide receptor 1, Soluble guanylate cyclase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Angina Pectoris Prevention
Fougera · 1 drug in Angina Pectoris Prevention
University Hospital, Ghent · 1 drug in Angina Pectoris Prevention

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Angina Pectoris Prevention:

Cite this brief

Drug Landscape (2026). Angina Pectoris Prevention — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/angina-pectoris-prevention. Accessed 2026-06-10.

Angina Pectoris Prevention full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing